This contrasts with previous findings showing lack of effect of single BH3-mimetic treatment in U87 tumours in vivo, thus emphasising a key role for multiple BCL-2 proteins in enabling GBM survival [27]. The gene discussed is BCL2; the disease is glioblastoma.